Related Experiment Video
Updated: Aug 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia
Heidi E Lilja1, Elina Suviolahti, Aino Soro-Paavonen
1Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland.
Insights
Genetic analysis of Finnish families revealed shared chromosomal regions linked to low HDL-cholesterol and familial combined hyperlipidemia. The study identified specific loci on chromosomes 10q11, 2q31, and 20q13.32 associated with lipid traits.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Metabolic Disorders
Background:
- Familial combined hyperlipidemia (FCHL) and low HDL-cholesterol (HDL-C) are common inherited lipid disorders. Both conditions increase the risk of premature coronary heart disease (CHD). Phenotypic similarities suggest shared genetic underpinnings.
- Previous genome scans identified three shared chromosomal regions (8q23.1, 16q23.3, 20q13.32) for low HDL-C and FCHL. Other loci for premature CHD (2q31, Xq24) and high triglycerides (TGs) (10q11) were also previously identified.
Purpose of the Study:
- To investigate shared chromosomal regions for familial dyslipidemias and premature coronary heart disease.
- To analyze linkage and association for lipid traits (HDL-C, TGs) in Finnish families with low HDL-C or FCHL.
Main Methods:
- Analysis of 67 microsatellite markers in 1,109 individuals from 92 families.
- Utilized both qualitative and quantitative lipid phenotypes for linkage and association analyses.
- Examined previously identified loci for CHD and TGs, alongside shared regions for low HDL-C and FCHL.
Main Results:
- Evidence for linkage (LOD score 3.2) on chromosome 10q11 for quantitative HDL-C.
- Significant association (P = 0.0006) at marker D10S546 on 10q11 for quantitative TGs.
- Association (P = 0.008) at D10S546 for a combined trait of HDL-C and TGs.
- Suggestive evidence for linkage for HDL-C on 2q31 and for TGs on 20q13.32.
Conclusions:
- Chromosome 10q11, previously linked to TGs, BMI, and obesity, harbors loci associated with quantitative TGs and a combined HDL-C/TG trait.
- Chromosomes 10q11, 2q31, and 20q13.32 are implicated in the genetic etiology of HDL-C and TG levels in Finnish families with dyslipidemias.
- These findings support the hypothesis of overlapping molecular pathogenesis in familial dyslipidemias predisposing to CHD.
Abstract:
Decreased HDL-cholesterol (HDL-C) and familial combined hyperlipidemia (FCHL) are the two most common familial dyslipidemias predisposing to premature coronary heart disease (CHD). These dyslipidemias share many phenotypic features, suggesting a partially overlapping molecular pathogenesis. This was supported by our previous pooled data analysis of the genome scans for low HDL-C and FCHL, which identified three shared chromosomal regions for a qualitative HDL-C trait on 8q23.1, 16q23.3, and 20q13.32. This study further investigates these regions as well as two other loci we identified earlier for premature CHD on 2q31 and Xq24 and a locus for high serum triglycerides (TGs) on 10q11. We analyzed 67 microsatellite markers in an extended study sample of 1,109 individuals from 92 low HDL-C or FCHL families using both qualitative and quantitative lipid phenotypes. These analyses provided evidence for linkage (a logarithm of odds score of 3.2) on 10q11 using a quantitative HDL-C trait. Importantly, this region, previously linked to TGs, body mass index, and obesity, provided evidence for association for quantitative TGs (P = 0.0006) and for a combined trait of HDL-C and TGs (P = 0.008) with marker D10S546. Suggestive evidence for linkage also emerged for HDL-C on 2q31 and for TGs on 20q13.32. Finnish families ascertained for dyslipidemias thus suggest that 10q11, 2q31, and 20q13.32 harbor loci for HDL-C and TGs.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
11:13Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
Published on: May 9, 2019
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents